Betmiga 25mg Tablets 30 Count – Effective Treatment for Overactive Bladder

Betmiga 25mg Tablet 30's

Description:

• Betmiga 25mg tablet is an antimuscarinic agent that contains an active ingredient called Mirabegron.
• It reduces the activity and symptoms associated with an overactive bladder, such as urgency incontinence, sudden urination urges, and increased urinary frequency.

Uses:

• Treatment of overactive bladder (OAB) symptoms.
• Helps to control uncontrollable bladder emptying (urgency incontinence).
• Reduces sudden urges to urinate.
• Reduces frequent urination.

Important Safety Information:

• Pregnancy: Betmiga 25mg tablet is unsafe during pregnancy as it may harm the developing baby. Consult your doctor.
• Breastfeeding: It is unsafe to use Betmiga 25mg tablet during breastfeeding because the medicine may pass into breast milk. Consult your doctor.
• Liver: Betmiga 25mg tablet is used with caution in patients with liver impairment. Inform your physician about the pre-existing liver conditions.
• High blood pressure: Do not take if you have high uncontrolled blood pressure.
• Allergies: Do not take if you have allergies to Mirabegron.
• Other conditions: Inform your doctor if you have trouble emptying your bladder (urinary retention) or any heart conditions, such as abnormal ECG (QT prolongation).

How to consume:

• Take the Betmiga 25mg tablet as your physician advises. Do not crush, chew, or open the medicine.
• Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.
• Only stop taking the tablet if your doctor advises you to stop.

Side Effects:

• Serious: irregular heartbeat, sudden or throbbing headache, angioedema (swelling of the face, mouth, or throat), elevated blood pressure.
• Common: increased heart rate, nausea, constipation, diarrhea, dizziness, urinary tract infection.

Interaction with other drugs:

• Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment.
• Certain medications, such as itraconazole, ketoconazole, and clarithromycin, may interact with Betmiga 25mg tablet and can cause undesirable side effects.

Storage:

• Keep out of sight and reach of pets and children.
• Do not freeze the medicine.
• Do not store above 30°C.
• Always check the expiry date before consuming it.

FAQ:

• Q1. Is Betmiga 25mg tablet an anticholinergic? No! Betmiga 25mg tablet is not an anticholinergic medication. It is a beta-3 adrenergic agonist that relaxes the bladder muscles to improve urinary symptoms.
• Q2. What is the best time of day to take the Betmiga 25mg tablet? The best time of day to take the Betmiga 25mg tablet can vary depending on the individual and healthcare provider's recommendation. It is generally recommended to follow the prescribed dosage instructions and take medicine at the same time each day for consistency.
• Q3. What are the side effects of the Betmiga 25mg tablet? Common side effects of Betmiga 25mg tablet include increased blood pressure, headache, dizziness, urinary tract infection, and constipation.
• Q4. How to manage the side effects of Betmiga 25mg tablet? To manage the side effects of the Betmiga 25mg tablet, follow your doctor's instructions, stay hydrated, and monitor blood pressure and any changes. Report severe side effects to your doctor and inform them about other medications or conditions.
• Q5. Can you take Betmiga 25mg tablet when pregnant? It is unsafe to consume this medicine while pregnant. Consult your medical professional regarding the use of Betmiga 25mg tablet during pregnancy.
• Q6. What should I do if I miss a dose of Betmiga 25mg tablet? If you miss a capsule dose, take it as soon as possible. However, if it's close to the time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose of Betmiga 25mg tablet.

Fact Box:

• Molecule Name: Mirabegron
• Therapeutic class: Urology
• Pharmacological class: beta 3-adrenoceptor agonist
• Indications:
  1. Treatment of overactive bladder (OAB) symptoms.
  2. Helps control uncontrollable bladder emptying (urgency incontinence).
  3. Reduces sudden urges to urinate.
  4. Reduces frequent urination.

Tags: betmiga, medication, 25mg, tablet, 30s, healthcare, drug, prescription, pharmacy